Dimethyl fumarate modulates the dystrophic disease program following short-term treatment

Export

Timpani, Cara ORCID: 0000-0003-4567-4319, Kourakis, Stephanie ORCID: 0000-0001-5683-9989, DeBruin, Danielle A ORCID: 0000-0003-1851-896X, Campelj, Dean G, Pompeani, Nancy, Dargahi, Narges ORCID: 0000-0001-8090-025X, Bautista, Angelo P, Bagaric, Ryan M, Ritenis, Elya J, Sahakian, Lauren, Debrincat, Didier, Stupka, Nicole, Hafner, Patricia, Arthur, Peter G, Terrill, Jessica R, Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771, de Haan, Judy B, Guven, Nuri, Fischer, Dirk and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2023) Dimethyl fumarate modulates the dystrophic disease program following short-term treatment. JCI Insight, 8 (21). ISSN 2379-3708

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/48052
DOI 10.1172/jci.insight.165974
Official URL http://dx.doi.org/10.1172/jci.insight.165974
Subjects Current > FOR (2020) Classification > 3202 Clinical sciences
Current > FOR (2020) Classification > 3208 Medical physiology
Current > Division/Research > Institute for Health and Sport
Keywords Duchenne muscular dystrophy; myogenic disease; prednisone; Dimethyl fumarate; diroximel fumarate; drug effects; clinical trial
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login

CORE (COnnecting REpositories)